Russell Investments Group, Ltd. Catalyst Biosciences, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$4.1 - $5.33 $219,202 - $284,963	-53,464 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$4.93 - $7.15 $15,470 - $22,436	-3,138 Reduced 5.54%	53,464 $269,000
Q4 2020 Feb 08, 2021	BUY	$4.55 - $7.29 $243,261 - $389,752	53,464 Added 1703.76%	56,602 $356,000
Q2 2020 Aug 05, 2020	BUY	$3.76 - $8.01 $11,798 - $25,135	3,138 New	3,138 $18,000
Q2 2019 Aug 09, 2019	SELL	$7.08 - $10.6 $381,541 - $571,234	-53,890 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$7.67 - $9.96 $413,336 - $536,744	53,890 New	53,890 $437,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.